This phase 2 study sought to determine whether concurrent pantoprazole would improve cisplatin-induced ototoxicity and nephrotoxicity in younger patients with osteosarcoma.
A previous single-site trial showed that patients with R/R B-cell ALL treated with tisagenlecleucel achieved high complete remission rates. In this study, investigators report on results after the scope of the study was expanded.
A cancer diagnosis is wrought with challenges for young adults. This article identifies the unique support needs for patients aged 20 to 39 years with cancer.
In this companion piece to our November column, we discuss the unique challenges to preserving the fertility of female patients with cancer and current options.
Increasing survival rates for AYA patients with cancer have heightened the importance of discussing fertility preservation options. In this column, we review the options for male patients and the significance of including a discussion of them as part of treatment planning.
Overweight teens in Israel had about a 53 percent higher risk for colon cancer as adults, researchers found.
Cancer treatment during childbearing years increased risk of preterm birth and delivering low birth weight babies.
AYAs continue to report lower social functioning scores than their peers 2 years after diagnosis.
Increased risks among live births for adolescent and young adult cancer survivors
The site of cancer care may partially explain survival differences between children and AYAs with ALL.
